microdosing glp 1 semaglutide GLP-1 ✨ A more personalized approach to weight management using smaller, strategic doses designed to support appetite control and metabolic balance. Every body is different, which is why we take the Benefits of GLP-1 Microdosing GLP-1

It received UK approval in September 2022 and has a substantial safety record with millions of users worldwide

Frequently asked questions (FAQs) GLP-1 nausea can be a persistent side effect, or can go away less than an hour after eating

In the STEP 1 trial, participants receiving semaglutide 2.4 mg weekly experienced significant reductions in triglycerides (mean decrease of 15-20%) and total cholesterol compared with placebo

Options include stepping back to a previous tolerated dose for an additional 4 weeks, reducing the current dose by half and escalating more slowly, or adding prescription anti-nausea medication (ondansetron is commonly used)